New Delhi (NVI): Russia’s Sechenov University claims that it has successfully completed the human trial round of the world’s first novel coronavirus vaccine, according to a report by Sputnik News.
In a statement the Russian varsity said it began clinical trials of the vaccine against Sars-Cov-2, which causes the coronavirus disease, on June 18. The vaccine was produced by Russia’s Gamaleya Institute of Epidemiology and Microbiology, it said.
The Russian ministry of health sanctioned the trial on June 16.
According to the media reports, the university said the first group of volunteers would be discharged on Wednesday and the second on July 20.
The university has said the first group of volunteers would be discharged on Wednesday and the second on July 20.
The method is not new and has been used for developing vaccines for seasonal flu, typhoid, malaria and cholera, among others.
However, there was no further information on when this vaccine would enter the commercial production stage.
There are at least 21 vaccines currently under key trials, according to the World Health Organisation (WHO).
So far, the total number of coronavirus cases have surpassed 12.9 million globally while the death toll has crossed 5,69,000.